NH SPAC 2 Cash Flow Conversion Efficiency

Latest as of December 2025: 0.043x

NH SPAC 2 cash flow conversion efficiency. Based on the latest financial reports, NH SPAC 2 (206640) has a cash flow conversion efficiency ratio of 0.043x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.46 Billion ≈ $7.09 Million USD) by net assets (₩244.18 Billion ≈ $165.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of NH SPAC 2 (2015–2025)

Cash flow conversion efficiency of NH SPAC 2 from 2015 to 2025. This chart illustrates how NH SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NH SPAC 2 (206640) share price today for real-time trading data and today's change.

NH SPAC 2 Cash Flow Conversion Ratio Explained

NH SPAC 2 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

NH SPAC 2 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NH SPAC 2 ranked by their cash flow conversion efficiency. Also see 206640 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Southern Hydropower JSC VN:SHP	0.058x
GaeaSoft Corp KQ:051160	0.034x
John Hancock Income Securities Closed Fund NYSE:JHS	0.026x
Mostostal Zabrze - Holding SA WAR:MSZ	-0.083x
RumbleON Inc NASDAQ:RMBL	-2.319x
Teladan Setia Group Bhd KLSE:0230	0.033x
Cancer Rop Co. Ltd. KQ:180400	-0.111x
JINSUNG T.E.C. Inc KQ:036890	-0.016x

Annual Cash Flow Conversion Efficiency for NH SPAC 2 (2015–2025)

The table below shows the annual cash flow conversion efficiency of NH SPAC 2 from 2015 to 2025. Review 206640 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩244.18 Billion ≈ $165.48 Million	₩22.08 Billion ≈ $14.96 Million	0.090x	-18.92%
2024-12-31	₩223.05 Billion ≈ $151.16 Million	₩24.88 Billion ≈ $16.86 Million	0.112x	-35.80%
2023-12-31	₩197.42 Billion ≈ $133.79 Million	₩34.30 Billion ≈ $23.24 Million	0.174x	+23.18%
2022-12-31	₩163.56 Billion ≈ $110.84 Million	₩23.07 Billion ≈ $15.63 Million	0.141x	-57.32%
2021-12-31	₩151.09 Billion ≈ $102.39 Million	₩49.93 Billion ≈ $33.83 Million	0.330x	-11.28%
2020-12-31	₩119.86 Billion ≈ $81.23 Million	₩44.64 Billion ≈ $30.25 Million	0.372x	+58.88%
2019-12-31	₩73.55 Billion ≈ $49.84 Million	₩17.24 Billion ≈ $11.68 Million	0.234x	+188.18%
2018-12-31	₩65.33 Billion ≈ $44.27 Million	₩5.31 Billion ≈ $3.60 Million	0.081x	+522.67%
2017-12-31	₩67.87 Billion ≈ $46.00 Million	₩886.74 Million ≈ $600.93K	0.013x	-91.67%
2016-12-31	₩75.17 Billion ≈ $50.94 Million	₩11.79 Billion ≈ $7.99 Million	0.157x	-3.10%
2015-12-31	₩59.50 Billion ≈ $40.32 Million	₩9.63 Billion ≈ $6.53 Million	0.162x	--

About NH SPAC 2

KQ:206640 Korea Medical Devices

Market Cap

$121.47 Million

₩179.25 Billion KRW

Market Cap Rank

#18264 Global

#802 in Korea

Share Price

₩8360.00

Change (1 day)

-1.76%

52-Week Range

₩8360.00 - ₩13970.00

All Time High

₩36222.75